NCT00452088 A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso Status UNKNOWN Phase PHASE1
NCT00451139 Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials Status COMPLETED Phase PHASE4
NCT00444106 Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function Status COMPLETED Phase PHASE4
NCT00443131 Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines Status COMPLETED Phase PHASE2
NCT00442442 Clinical Evaluation of Mosquito Coils to Control Malaria in China Status UNKNOWN Phase PHASE3
NCT00442403 Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria Status SUSPENDED Phase PHASE3
NCT00440999 Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria Status COMPLETED Phase PHASE3
NCT00436007 Safety and Immunogenicity Study of GSK Biologicals' Malaria Vaccine 257049, When Incorporated Into an EPI Regimen Status COMPLETED Phase PHASE2
NCT00432367 Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy Status COMPLETED Phase PHASE3
NCT00431808 Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545]) Status UNKNOWN Phase PHASE1
NCT00427167 Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine Status COMPLETED Phase PHASE1
NCT00425763 Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria Status COMPLETED Phase PHASE4
NCT00424944 Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine Status UNKNOWN Phase PHASE1
NCT00422084 Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients Status COMPLETED Phase PHASE3
NCT00421473 Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients Status COMPLETED Phase PHASE4
NCT00414479 Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment Status COMPLETED Phase N/A
NCT00414336 Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria Status COMPLETED Phase PHASE1
NCT00408668 Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen Status COMPLETED Phase PHASE1/PHASE2